Analisis Skor Reflux Symptom Index (RSI) pada Pasien Laryngopharyngeal Reflux dengan Pemberian Lansoprazol dan Ranitidin di RSUP Dr M Djamil Padang
DOI:
https://doi.org/10.25077/jokli.v3i1.60Keywords:
Lansoprazole, Laryngopharyngeal reflux, Ranitidin, Reflux symptom indexAbstract
Laryngopharyngeal reflux (LPR) is a condition caused by the movement of stomach acid back into the pharynx, larynx and upper digestive tract. One of the diagnostic tools that can be used in LPR is the Reflux Symptom Index (RSI), where RSI can also be used to evaluate symptom improvement in patients before and after administering drug therapy. This study aims to determine the average RSI score before and after giving therapy to LPR patients at Dr M Djamil Hospital, Padang.
This research is a retrospective analytical study by taking medical record data on LPR patients at Dr M Djamil Hospital Padang using consecutive sampling techniques. Data analysis was carried out univariately to determine the frequency distribution and bivariately using the paired T-test to analyze the average RSI score.
The results of this study were that the majority of LPR sufferers were >50 years old (52.9%), the majority gender was female (76.2%), and the most common complaints were a lump in the throat (100%) and heartburn (100%). The average RSI score before giving therapy was found to be 22.12 ± 6.827 and after giving therapy was 13.18 ± 7.844. Based on the data analysis carried out, the p<0.001.
The conclusion of this study was that there was a significant change in the average RSI value before and after administration of lansoprazole and ranitidine therapy in LPR patients.
References
Yunizaf MH, Iskandar N. Penyakit refluks gastroesofagus dengan manifestasi otolaringologi. In: Buku ajar ilmu kesehatan telinga hidung tenggorok bedah kepala dan leher. Jakarta: Badan Penerbit FKUI; 2015. p. 270–3.
Tae K, Jin BJ, Ji YB, Jeong JH, Cho SH, Lee SH. The role of laryngopharyngeal reflux as a risk factor in laryngeal cancer: A preliminary report. Clin Exp Otorhinolaryngol. 2011;4(2):101–4
Campagnolo AM, Priston J, Thoen RH, Medeiros T, Assunção AR. Laryngopharyngeal reflux: Diagnosis, treatment, and latest research. Int Arch Otorhinolaryngol. 2014;18(2):184–91.
Afifah F, Fitri F, Amir A. Karakteristik Penderita Laryngopharyngeal Reflux di Bagian THT-KL RSUP Dr. M. Djamil Padang Tahun 2019. Jurnal Ilmu Kesehatan Indonesia. 2021;2(1):99.
Sa’an NB. Gambaran Pasien Laryngopharyngeal Reflux di Bagian Poliklinik THT-KL RSUP Dr. M. Djamil Padang Periode 2017. Jurnal Ilmu Kesehatan Indonesia. 2020;1:44–5.
Endah S, Putri E, Yusmawan W, Yunika K. Perbedaan skor RSI penderita Laryngopharyngeal Reflux Yang Mendapat omeprazol dan lansoprazole. Jurnal Kedokteran Diponegoro (Diponegoro Medical Journal). 2018;7:349.
Marlina L, Hendrika W. Description Of Laryngopharnygeal Reflux Patients Based On Reflux Symptom Index (RSI) After PPI Administration At UKI General Hospital. 2022;6(1):20–1.
Shin JM, Sachs G. Pharmacology of proton pump inhibitors. Curr Gastroenterol Rep. 2008;10(6):528–34.
Sandriani Y. Desain Optimasi Dan Evaluasi Floating Tablet Ranitidin Menggunakan Kombinasi Polimer Hpmc Dan Carbopol Dengan Metode Simplex Lattice Design. Vol. 8, Universitas Islam Indonesia. 2019.
Nunes HS, Pinto JA, Zavanela AR, Cavallini AF, Freitas GS, Garcia FE. Comparison between the Reflux Finding Score and the Reflux Symptom Index in the Practice of Otorhinolaryngology. Int Arch Otorhinolaryngol. 2016;20:218–21.
Asyari A, Amri D, Novialdi, Fitri F, Yerizal E, Bachtiar H, et al. Deteksi pepsin pada saliva pasien refluks laringofaring. Oto Rhino Laryngologica Indonesiana. 2018;48(1):68.
Febriyanti R. Perbedaan Kualitas Hidup pada Penderita Refluks Laringofaring Sebelum dan Sesudah Pemberian Omeprazole di RSUP H. Adam Malik Medan. Universitas Sumatera Utara; 2014.
Munifah AP, Perdana RF, Juniati SH, Yusuf M, Dewi ER. The profile of laryngopharyngeal reflux patients at Dr. Soetomo teaching hospital, Surabaya Indonesia. Indian Journal of Forensic Medicine and Toxicology. 2020;14(4):4160–6.
Kurniawati T, Madiadipoera T, Sarbini TB, Saifuddin OM. Perbandingan Efektivitas antara Omeprazol dan Lansoprazol terhadap Perbaikan Kualitas Hidup Penderita Rinosinusitis Kronik Akibat Refluks Laringofaring. Majalah Kedokteran Bandung. 2012;44(3):138–46.
Andriani Y, Akil MA, Gaffar M, Punagi AQ. Deteksi pepsin pada penderita refluks laringofaring yang didiagnosis berdasarkan reflux symptom index dan reflux finding score. Oto Rhino Laryngologica Indonesiana. 2011;41(2):123–4.
Kirihena KDRA, Gunarathna CK. Laryngopharyngeal reflux disease in a series of Sri Lankan patients. Ceylon Journal of Otolaryngology. 2015;4(1):9–12.
Massawe WA, Nkya A, Abraham ZS, Babu KM, Moshi N, Kahinga AA, et al. Laryngopharyngeal reflux disease, prevalence and clinical characteristics in ENT department of a tertiary hospital Tanzania. World J Otorhinolaryngol Head Neck Surg. 2021;28–33.
Lee BE, Kim GH. Globus pharyngeus: A review of its etiology, diagnosis and treatment. World J Gastroenterol. 2012;18(20):2462–71.
Stinnett S, Dhillon V, Akst L. Laryngopharyngeal Reflux: Current Concepts on Etiology and Pathophysiology and Its Role in Dysphagia. Curr Otorhinolaryngol Rep. 2018;6(2):196–202.
Han SY, Kim GH. Clinical manifestations of laryngopharyngeal reflux. J Neurogastroenterol Motil. 2016;22(3):351
Sirajuddin SHP. Reflux Symptom Index (RSI) and Reflux Finding Score (RFS) in Management of Laryngopharyngeal Reflux in Indian Scenario. International Journal of Clinical & Experimental Otolaryngology. 2020;6(2):11
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Muhammad Rofid Adha, Ade Asyari, Asrawati, Elly Usman, Syandrez Prima Putra

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.











